Home > > > > Report Detail

Global Drugs for Schistosomiasis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 02-Sep-2022
No. of pages: 104
Inquire Before Buying

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Drugs for Schistosomiasis market is projected to reach US$ 106.8 million by 2028 from an estimated US$ 85 million in 2022, at a CAGR of 3.8% during 2023 and 2028.

Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.

East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,

Followed by West Africa(20%).

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drugs for Schistosomiasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Drugs for Schistosomiasis.

The Drugs for Schistosomiasis market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drugs for Schistosomiasis market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs for Schistosomiasis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Shin Poong

- Merck

- Bayer

- EIPICO

- Chandra Bhagat Pharma

- Taj Pharmaceuticals

Product Type Insights

Global markets are presented by Drugs for Schistosomiasis type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Drugs for Schistosomiasis are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Drugs for Schistosomiasis Segment by Type

- Praziquantel

- Oxamniquine

- Other

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Drugs for Schistosomiasis market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drugs for Schistosomiasis market.

Drugs for Schistosomiasis Segment by Application

- S. haematobium

- S. mansoni

- S. japonicum

- S. mekongi

- S. intercalatum

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Drugs for Schistosomiasis market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Schistosomiasis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Drugs for Schistosomiasis and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drugs for Schistosomiasis industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Schistosomiasis

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Drugs for Schistosomiasis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Drugs for Schistosomiasis Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Market by Application
1.3.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drugs for Schistosomiasis Market Size Estimates and Forecasts
2.1.1 Global Drugs for Schistosomiasis Revenue 2017-2028
2.1.2 Global Drugs for Schistosomiasis Sales 2017-2028
2.2 Drugs for Schistosomiasis Market Size by Region: 2022 Versus 2028
2.3 Drugs for Schistosomiasis Sales by Region (2017-2028)
2.3.1 Global Drugs for Schistosomiasis Sales by Region: 2017-2022
2.3.2 Global Drugs for Schistosomiasis Sales Forecast by Region (2023-2028)
2.3.3 Global Drugs for Schistosomiasis Sales Market Share by Region (2017-2028)
2.4 Drugs for Schistosomiasis Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Drugs for Schistosomiasis Revenue by Region: 2017-2022
2.4.2 Global Drugs for Schistosomiasis Revenue Forecast by Region (2023-2028)
2.4.3 Global Drugs for Schistosomiasis Revenue Market Share by Region (2017-2028)
3 Global Drugs for Schistosomiasis by Manufacturers
3.1 Global Top Drugs for Schistosomiasis Manufacturers by Sales
3.1.1 Global Drugs for Schistosomiasis Sales by Manufacturer (2017-2022)
3.1.2 Global Drugs for Schistosomiasis Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Drugs for Schistosomiasis Manufacturers by Revenue
3.2.1 Global Drugs for Schistosomiasis Revenue by Manufacturer (2017-2022)
3.2.2 Global Drugs for Schistosomiasis Revenue Share by Manufacturer (2017-2022)
3.3 Global Drugs for Schistosomiasis Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Drugs for Schistosomiasis Manufacturers Covered: Ranking by Revenue
3.4.2 Global Drugs for Schistosomiasis Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Drugs for Schistosomiasis Manufacturing Base Distribution, Product Type
3.5.1 Drugs for Schistosomiasis Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Drugs for Schistosomiasis Product Type
3.5.3 Date of International Manufacturers Enter into Drugs for Schistosomiasis Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Shin Poong
4.1.1 Shin Poong Corporation Information
4.1.2 Shin Poong Description, Business Overview
4.1.3 Shin Poong Drugs for Schistosomiasis Products Offered
4.1.4 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Shin Poong Drugs for Schistosomiasis Sales by Product in 2021
4.1.6 Shin Poong Drugs for Schistosomiasis Sales by Application in 2021
4.1.7 Shin Poong Drugs for Schistosomiasis Sales by Geographic Area in 2021
4.1.8 Shin Poong Recent Developments
4.2 Merck
4.2.1 Merck Corporation Information
4.2.2 Merck Description, Business Overview
4.2.3 Merck Drugs for Schistosomiasis Products Offered
4.2.4 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Merck Drugs for Schistosomiasis Sales by Product in 2021
4.2.6 Merck Drugs for Schistosomiasis Sales by Application in 2021
4.2.7 Merck Drugs for Schistosomiasis Sales by Geographic Area in 2021
4.2.8 Merck Recent Developments
4.3 Bayer
4.3.1 Bayer Corporation Information
4.3.2 Bayer Description, Business Overview
4.3.3 Bayer Drugs for Schistosomiasis Products Offered
4.3.4 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Bayer Drugs for Schistosomiasis Sales by Product in 2021
4.3.6 Bayer Drugs for Schistosomiasis Sales by Application in 2021
4.3.7 Bayer Drugs for Schistosomiasis Sales by Geographic Area in 2021
4.3.8 Bayer Recent Developments
4.4 EIPICO
4.4.1 EIPICO Corporation Information
4.4.2 EIPICO Description, Business Overview
4.4.3 EIPICO Drugs for Schistosomiasis Products Offered
4.4.4 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2017-2022)
4.4.5 EIPICO Drugs for Schistosomiasis Sales by Product in 2021
4.4.6 EIPICO Drugs for Schistosomiasis Sales by Application in 2021
4.4.7 EIPICO Drugs for Schistosomiasis Sales by Geographic Area in 2021
4.4.8 EIPICO Recent Developments
4.5 Chandra Bhagat Pharma
4.5.1 Chandra Bhagat Pharma Corporation Information
4.5.2 Chandra Bhagat Pharma Description, Business Overview
4.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Products Offered
4.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales by Product in 2021
4.5.6 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales by Application in 2021
4.5.7 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales by Geographic Area in 2021
4.5.8 Chandra Bhagat Pharma Recent Developments
4.6 Taj Pharmaceuticals
4.6.1 Taj Pharmaceuticals Corporation Information
4.6.2 Taj Pharmaceuticals Description, Business Overview
4.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Products Offered
4.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Taj Pharmaceuticals Drugs for Schistosomiasis Sales by Product in 2021
4.6.6 Taj Pharmaceuticals Drugs for Schistosomiasis Sales by Application in 2021
4.6.7 Taj Pharmaceuticals Drugs for Schistosomiasis Sales by Geographic Area in 2021
4.6.8 Taj Pharmaceuticals Recent Development
5 Breakdown Data by Type
5.1 Global Drugs for Schistosomiasis Sales by Type (2017-2028)
5.1.1 Global Drugs for Schistosomiasis Sales by Type (2017-2022)
5.1.2 Global Drugs for Schistosomiasis Sales Forecast by Type (2023-2028)
5.1.3 Global Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
5.2 Global Drugs for Schistosomiasis Revenue Forecast by Type (2017-2028)
5.2.1 Global Drugs for Schistosomiasis Revenue by Type (2017-2022)
5.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Type (2023-2028)
5.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
5.3 Drugs for Schistosomiasis Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Drugs for Schistosomiasis Sales by Application (2017-2028)
6.1.1 Global Drugs for Schistosomiasis Sales by Application (2017-2022)
6.1.2 Global Drugs for Schistosomiasis Sales Forecast by Application (2023-2028)
6.1.3 Global Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
6.2 Global Drugs for Schistosomiasis Revenue Forecast by Application (2017-2028)
6.2.1 Global Drugs for Schistosomiasis Revenue by Application (2017-2022)
6.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Application (2023-2028)
6.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
6.3 Drugs for Schistosomiasis Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Drugs for Schistosomiasis Market Size YoY Growth 2017-2028
7.2 North America Drugs for Schistosomiasis Market Facts & Figures by Country
7.2.1 North America Drugs for Schistosomiasis Sales by Country (2017-2028)
7.2.2 North America Drugs for Schistosomiasis Revenue by Country (2017-2028)
7.3 North America Drugs for Schistosomiasis Sales by Type
7.4 North America Drugs for Schistosomiasis Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Schistosomiasis Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Drugs for Schistosomiasis Market Facts & Figures by Region
8.2.1 Asia-Pacific Drugs for Schistosomiasis Sales by Region (2017-2028)
8.2.2 Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2017-2028)
8.3 Asia-Pacific Drugs for Schistosomiasis Sales by Type
8.4 Asia-Pacific Drugs for Schistosomiasis Sales by Application
9 Europe
9.1 Europe Drugs for Schistosomiasis Market Size YoY Growth 2017-2028
9.2 Europe Drugs for Schistosomiasis Market Facts & Figures by Country
9.2.1 Europe Drugs for Schistosomiasis Sales by Country (2017-2028)
9.2.2 Europe Drugs for Schistosomiasis Revenue by Country (2017-2028)
9.3 Europe Drugs for Schistosomiasis Sales by Type
9.4 Europe Drugs for Schistosomiasis Sales by Application
10 Latin America
10.1 Latin America Drugs for Schistosomiasis Market Size YoY Growth 2017-2028
10.2 Latin America Drugs for Schistosomiasis Market Facts & Figures by Country
10.2.1 Latin America Drugs for Schistosomiasis Sales by Country (2017-2028)
10.2.2 Latin America Drugs for Schistosomiasis Revenue by Country (2017-2028)
10.3 Latin America Drugs for Schistosomiasis Sales by Type
10.4 Latin America Drugs for Schistosomiasis Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Drugs for Schistosomiasis Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Drugs for Schistosomiasis Market Facts & Figures by Country
11.2.1 Middle East and Africa Drugs for Schistosomiasis Sales by Country (2017-2028)
11.2.2 Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2017-2028)
11.3 Middle East and Africa Drugs for Schistosomiasis Sales by Type
11.4 Middle East and Africa Drugs for Schistosomiasis Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Drugs for Schistosomiasis Supply Chain Analysis
12.2 Drugs for Schistosomiasis Key Raw Materials and Upstream Suppliers
12.3 Drugs for Schistosomiasis Clients Analysis
12.4 Drugs for Schistosomiasis Sales Channel and Sales Model Analysis
12.4.1 Drugs for Schistosomiasis Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Drugs for Schistosomiasis Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Drugs for Schistosomiasis Distributors
13 Market Dynamics
13.1 Drugs for Schistosomiasis Industry Trends
13.2 Drugs for Schistosomiasis Market Drivers
13.3 Drugs for Schistosomiasis Market Challenges
13.4 Drugs for Schistosomiasis Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Drugs for Schistosomiasis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Praziquantel
Table 3. Major Manufacturers of Oxamniquine
Table 4. Major Manufacturers of Other
Table 5. Global Drugs for Schistosomiasis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Drugs for Schistosomiasis Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 7. Global Drugs for Schistosomiasis Sales by Region (2017-2022) & (M Units)
Table 8. Global Drugs for Schistosomiasis Sales Forecast by Region (2023-2028) & (M Units)
Table 9. Global Drugs for Schistosomiasis Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Drugs for Schistosomiasis Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 11. Global Drugs for Schistosomiasis Sales by Manufacturer (2017-2022) & (M Units)
Table 12. Global Drugs for Schistosomiasis Sales Share by Manufacturer (2017-2022)
Table 13. Drugs for Schistosomiasis Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 14. Drugs for Schistosomiasis Revenue Share by Manufacturer (2017-2022)
Table 15. Key Manufacturers Drugs for Schistosomiasis Price (2017-2022) & (USD/K Units)
Table 16. Ranking of Global Top Drugs for Schistosomiasis Manufacturers by Revenue (US$ Million) in 2021
Table 17. Global Drugs for Schistosomiasis Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 18. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2021)
Table 19. Drugs for Schistosomiasis Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Drugs for Schistosomiasis Product Type
Table 21. Date of International Manufacturers Enter into Drugs for Schistosomiasis Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Shin Poong Corporation Information
Table 24. Shin Poong Description and Business Overview
Table 25. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 26. Shin Poong Drugs for Schistosomiasis Product
Table 27. Shin Poong Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Product in 2021
Table 28. Shin Poong Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Application in 2021
Table 29. Shin Poong Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2021
Table 30. Shin Poong Recent Development
Table 31. Merck Corporation Information
Table 32. Merck Description and Business Overview
Table 33. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 34. Merck Drugs for Schistosomiasis Product
Table 35. Merck Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Product in 2021
Table 36. Merck Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Application in 2021
Table 37. Merck Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2021
Table 38. Merck Recent Development
Table 39. Bayer Corporation Information
Table 40. Bayer Description and Business Overview
Table 41. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 42. Bayer Drugs for Schistosomiasis Product
Table 43. Bayer Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Product in 2021
Table 44. Bayer Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Application in 2021
Table 45. Bayer Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2021
Table 46. Bayer Recent Development
Table 47. EIPICO Corporation Information
Table 48. EIPICO Description and Business Overview
Table 49. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 50. EIPICO Drugs for Schistosomiasis Product
Table 51. EIPICO Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Product in 2021
Table 52. EIPICO Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Application in 2021
Table 53. EIPICO Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2021
Table 54. EIPICO Recent Development
Table 55. Chandra Bhagat Pharma Corporation Information
Table 56. Chandra Bhagat Pharma Description and Business Overview
Table 57. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 58. Chandra Bhagat Pharma Drugs for Schistosomiasis Product
Table 59. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Product in 2021
Table 60. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Application in 2021
Table 61. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2021
Table 62. Chandra Bhagat Pharma Recent Development
Table 63. Taj Pharmaceuticals Corporation Information
Table 64. Taj Pharmaceuticals Description and Business Overview
Table 65. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 66. Taj Pharmaceuticals Drugs for Schistosomiasis Product
Table 67. Taj Pharmaceuticals Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Product in 2021
Table 68. Taj Pharmaceuticals Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Application in 2021
Table 69. Taj Pharmaceuticals Drugs for Schistosomiasis Sales Proportion of Drugs for Schistosomiasis by Geographic Area in 2021
Table 70. Global Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 71. Global Drugs for Schistosomiasis Sales Forecast by Type (2023-2028) & (M Units)
Table 72. Global Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
Table 73. Global Drugs for Schistosomiasis Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 74. Global Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 75. Global Drugs for Schistosomiasis Sales Forecast by Application (2023-2028) & (M Units)
Table 76. Global Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
Table 77. Global Drugs for Schistosomiasis Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 78. North America Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
Table 79. North America Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
Table 80. North America Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
Table 81. North America Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
Table 82. North America Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 83. North America Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 84. Asia-Pacific Drugs for Schistosomiasis Sales by Region (2017-2022) & (M Units)
Table 85. Asia-Pacific Drugs for Schistosomiasis Sales by Region (2023-2028) & (M Units)
Table 86. Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2017-2028) & (US$ Million)
Table 87. Asia-Pacific Drugs for Schistosomiasis Revenue by Region (2023-2028) & (US$ Million)
Table 88. Asia-Pacific Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 89. Asia-Pacific Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 90. Europe Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
Table 91. Europe Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
Table 92. Europe Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
Table 93. Europe Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
Table 94. Europe Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 95. Europe Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 96. Latin America Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
Table 97. Latin America Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
Table 98. Latin America Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
Table 100. Latin America Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 101. Latin America Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 102. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
Table 103. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
Table 104. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 107. Middle East and Africa Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 108. Drugs for Schistosomiasis Key Raw Materials, Industry Status and Trend
Table 109. Drugs for Schistosomiasis Key Raw Materials and Upstream Suppliers
Table 110. Drugs for Schistosomiasis Clients Status and Trend
Table 111. Drugs for Schistosomiasis Typical Clients
Table 112. Drugs for Schistosomiasis Distributors
Table 113. Drugs for Schistosomiasis Market Trends
Table 114. Drugs for Schistosomiasis Market Drivers
Table 115. Drugs for Schistosomiasis Market Challenges
Table 116. Drugs for Schistosomiasis Market Restraints
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Schistosomiasis Product Picture
Figure 2. Global Drugs for Schistosomiasis Sales Market Share by Type in 2021 & 2028
Figure 3. Praziquantel Product Picture
Figure 4. Oxamniquine Product Picture
Figure 5. Other Product Picture
Figure 6. Global Drugs for Schistosomiasis Sales Market Share by Application in 2021 & 2028
Figure 7. S. haematobium Examples
Figure 8. S. mansoni Examples
Figure 9. S. japonicum Examples
Figure 10. S. mekongi Examples
Figure 11. S. intercalatum Examples
Figure 12. Drugs for Schistosomiasis Report Years Considered
Figure 13. Global Drugs for Schistosomiasis Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Drugs for Schistosomiasis Market Size 2017-2028 (US$ Million)
Figure 15. Global Drugs for Schistosomiasis Sales 2017-2028 (M Units)
Figure 16. Global Drugs for Schistosomiasis Market Size Market Share by Region: 2022 Versus 2028
Figure 17. Global Drugs for Schistosomiasis Sales Market Share Forecast by Region (2017-2028)
Figure 18. Global Drugs for Schistosomiasis Revenue Market Share by Region (2017-2028)
Figure 19. Global Drugs for Schistosomiasis Sales Share by Manufacturer in 2021
Figure 20. Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Drugs for Schistosomiasis Sales Market Share Forecast by Type (2017-2028)
Figure 22. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Type (2017-2028)
Figure 23. Drugs for Schistosomiasis Average Selling Price (ASP) by Type (2017-2022) & (USD/K Units)
Figure 24. Global Drugs for Schistosomiasis Sales Market Share Forecast by Application (2017-2028)
Figure 25. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Application (2017-2028)
Figure 26. Drugs for Schistosomiasis Average Selling Price (ASP) by Application (2017-2022) & (USD/K Units)
Figure 27. North America Drugs for Schistosomiasis Revenue 2017-2028 (US$ Million)
Figure 28. North America Drugs for Schistosomiasis Sales Market Share by Type (2017-2022)
Figure 29. North America Drugs for Schistosomiasis Sales Market Share by Application (2017-2022)
Figure 30. Asia-Pacific Drugs for Schistosomiasis Revenue 2017-2028 (US$ Million)
Figure 31. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Region (2017-2028)
Figure 32. Asia-Pacific Drugs for Schistosomiasis Revenue Market Share by Region (2017-2028)
Figure 33. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Type (2017-2022)
Figure 34. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Application (2017-2022)
Figure 35. Europe Drugs for Schistosomiasis Revenue Growth Rate 2017-2028 (US$ Million)
Figure 36. Europe Drugs for Schistosomiasis Sales Market Share by Country (2017-2028)
Figure 37. Europe Drugs for Schistosomiasis Revenue Market Share by Country (2017-2028)
Figure 38. Europe Drugs for Schistosomiasis Sales Market Share by Type (2017-2022)
Figure 39. Europe Drugs for Schistosomiasis Sales Market Share by Application (2017-2022)
Figure 40. Latin America Drugs for Schistosomiasis Revenue Growth Rate 2017-2028 (US$ Million)
Figure 41. Latin America Drugs for Schistosomiasis Sales Market Share by Country (2017-2028)
Figure 42. Latin America Drugs for Schistosomiasis Revenue Market Share by Country (2017-2022)
Figure 43. Latin America Drugs for Schistosomiasis Sales Market Share by Type (2017-2022)
Figure 44. Latin America Drugs for Schistosomiasis Sales Market Share by Application (2017-2022)
Figure 45. Middle East and Africa Drugs for Schistosomiasis Revenue Growth Rate 2017-2028 (US$ Million)
Figure 46. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Country (2017-2028)
Figure 47. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Country (2017-2028)
Figure 48. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Type (2017-2022)
Figure 49. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Application (2017-2022)
Figure 50. Drugs for Schistosomiasis Supply Chain (Upstream and Downstream Market)
Figure 51. Global Production Market Share of Drugs for Schistosomiasis Raw Materials by Region in 2021
Figure 52. Drugs for Schistosomiasis Distribution Channels
Figure 53. Global Drugs for Schistosomiasis Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 54. Global Drugs for Schistosomiasis Percentage 2017-2028: Online Sales VS Offline Sales
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs